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Introduction 
Cutaneous reactions to radiation therapy include 
acute dermatitis, chronic dermatitis, keratosis-like 
nodules (called pseudorecidives), and lichen 
planus [1, 3]. Radiation-associated dermatitis may 
present with erythematous, edematous, 
desquamating, ulcerative, or fibrotic changes, 
whereas pseudorecidives present as 
spontaneously resolving keratoses, which tend to 
appear immediately after irradiation [1, 2]. 
Cutaneous lichen planus is classically 
characterized by violaceous, pruritic, polygonal, 
planar papules and plaques, most commonly 
affecting the extremities [2]. In addition to the 
skin, lichen planus may affect the mucous 
membranes, hair, and nails [2]. The surface of the 
lesion often presents with a reticular pattern of 
fine, white streaks or punctations referred to as 
Wickham striae [2]. Lichen planus following 
radiation therapy is uncommon, and lichen planus 
following radiation therapy for prostate 
carcinoma has not been previously reported. We 
report a patient who developed hypertrophic 
lichen planus following radiation therapy for 
prostate adenocarcinoma. 
 
Case Synopsis 
A 66-year-old man presented to the dermatology 
clinic with a symmetric pruritic eruption of the 
Abstract 
Cutaneous lichen planus is classically 
characterized by violaceous, pruritic, planar 
papules and plaques, most commonly affecting 
the extremities. Lichen planus following radiation 
therapy is extremely rare and lichen planus 
following radiation therapy for prostate carcinoma 
has not been previously reported in the literature. 
We report a 66-year-old man who presented to 
the dermatology clinic with a symmetric pruritic 
eruption affecting the pelvic and gluteal region 
within two months of radiation therapy targeting 
the prostate and pelvic lymph nodes for prostate 
adenocarcinoma. The patient did not have a prior 
history of lichen planus. Physical examination 
demonstrated well demarcated, violaceous 
papules and plaques in a circumferential band-like 
distribution on the bilateral gluteal, lumbosacral, 
and pelvic region. In addition, he had a few 
discrete lesions on the calves and dorsal feet. 
Punch biopsy revealed an acanthotic epidermis 
with “saw-tooth” rete ridges and a lichenoid 
inflammatory infiltrate. A diagnosis of 
hypertrophic lichen planus was made, reinforcing 
the importance for clinicians to recognize 
radiation therapy as a risk factor for developing 
lichen planus despite no prior history of lichen 
planus. 
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pelvic and gluteal region. He had been treated 
with radiotherapy for prostate adenocarcinoma 
and noted the skin lesions after about two months 
of the radiation therapy. Treatment consisted of 
primary radiotherapy with an initial 4400cGy to 
the prostate and pelvic lymph nodes (Figure 1), 
followed by a boost such that the prostate 
received a total of 7800cGy over 39 treatment 
sessions. Total skin dose was approximately 
400cGy delivered over the 39 treatments for 
about 10cGy per treatment. The radiation 
treatment technique used for the high dose 
“boost” to the prostate gland was “Volumetric 
Modulated Arc Treatment” (VMAT), in which the 
treatment machine delivered a beam of radiation 
as it rotated around the patient. Volumetric 
Modulated Arc Treatment concentrated the 
prescription high dose on the internal target, the 
prostate, and delivered a small “entry” dose to the 
skin and internal tissue between the skin and the 
target (prostate). Historically, radiation treatment 
was delivered through static “ports” such that the 
dose was not spread out as much and one would 
expect more skin reaction at the skin site of the 
port. In this case, the VMAT technique kept the 
radiation entry dose acceptably low, below the 
usual threshold to trigger a skin reaction such as 
erythema. However, on analysis, the skin exposed 
to low dose radiation as the treatment machine 
rotated around the patient corresponded to the 
main areas of skin involvement. The patient’s past 
medical history was significant for treated 
hepatitis C and he did not have any prior history 
of lichen planus. 
Physical examination revealed well demarcated, 
violaceous papules and plaques in a 
circumferential band-like distribution on the 
bilateral gluteal, lumbosacral, and pelvic region 
(Figure 2), with isolated lesions on the bilateral 
calves and dorsal feet. Punch biopsy 
demonstrated an acanthotic epidermis with “saw-
tooth” rete ridges, necrotic keratinocytes along 
the basal layer and scattered within the spinous 
layer, and a dense infiltrate of lymphocytes and 
melanophages that filled the papillary dermis and 
focally obscured the dermal-epidermal junction 
(Figure 3), consistent with a diagnosis of 
hypertrophic lichen planus. Hepatitis C RNA was 
negative.  
 
Figure 1. Radiation targeted the prostate and pelvic lymph 
nodes with Volumetric Modulated Arc Treatment, in which 
the treatment machine delivered a beam of radiation as it 
rotated around the patient. Dosage ranged from 
approximately 400cGy (blue) to approximately 7700cGy 
(red) in the radiation field. 
 
 
Figure 2. Physical examination revealed well demarcated, 
violaceous papules and plaques in a circumferential band-
like distribution on the bilateral gluteal, lumbosacral, and 
pelvic region. 
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Case Discussion 
Risk factors for lichen planus include trauma, 
hepatitis, certain medications, autoimmune 
diseases, and malignancies [2]. Lichen planus 
following radiotherapy is extremely rare, and to 
the best of our knowledge, lichen planus 
following radiotherapy for prostate cancer has not 
been previously reported in the literature [3]. The 
cases of oncological radiotherapy-associated 
lichen planus reported in the English literature are 
summarized in Table 1. Upon review of the 
literature, including our case, the average age of 
onset was 58 years, and 54% (7/13) of patients 
were female [3-15], (Table 1). The average onset 
of lichenoid reaction was within three months of 
a mean total radiation dose of 50 Gy [3-15], (Table 
1). Most cases reported a generalized distribution 
extending beyond the localized radiation field [3-
5], (Table 1). 
Although the pathophysiology of lichen planus 
has yet to be fully elucidated, an aberrant 
lymphocyte-mediated inflammatory reaction has 
been implicated in its pathogenesis [2, 3]. It has  
been proposed that radiotherapy may induce a 
lichenoid reaction owing to cellular injury and 
release of keratinocyte self-antigens, thereby 
instigating a local inflammatory response [3, 10, 
15]. This phenomenon is also referred to as 
radiation-induced koebnerization with an 
isoradiotopic response [10, 15]. The locations of 
our patient’s lesions correspond to the radiation 
port with minimal extension into the surrounding 
region; thus, radiation-induced koebnerization 
with isoradiotopic response is the likely 
mechanism for our patient’s condition. 
Another mechanism that has been described in 
the literature is Wolf isotopic response, which is 
the new onset of a dermatosis in the same 
anatomic site as a previously resolved, different 
dermatosis [12]. For example, cases of lichen 
planus arising in a location that has previously 
been affected by herpes zoster or 
dermatofibrosarcoma protuberans have been 
reported [12]. However, our patient had not 
experienced any notable skin lesions in the 
affected areas beforehand and his past medical 
history was negative for herpes zoster or varicella. 
Furthermore, although our patient’s clinical 
presentation may resemble zosteriform lichen 
planus, the presenting distribution did not 
precisely follow sacral dermatomal distribution 
and zosteriform lichen planus usually presents 
unilaterally [16], unlike our patient. 
As hepatitis C is also a risk factor, it is possible that 
our patient’s history of hepatitis C may have 
played a contributory role to developing lichen 
planus in response to the precipitating event of 
radiation-associated trauma. Therefore, it is 
important for clinicians to gather a thorough 
patient history and recognize recent radiotherapy 
as an additional risk factor. Furthermore, owing to 
the risk of non-melanoma skin cancer associated 
with radiotherapy [1] and lichen planus [17], 
longitudinal follow-up for patients with radiation-
associated lichen planus may be prudent. 
 
Figure 3. Histology demonstrated an acanthotic epidermis 
with “saw-tooth” rete ridges, necrotic keratinocytes along the 
basal layer and scattered within the spinous layer, and a 
dense infiltrate of lymphocytes and melanophages that fill 
the papillary dermis and focally obscure the dermal-
epidermal junction (hematoxylin & eosin, original 
magnification x100). 
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Treatment of radiotherapy-associated lichen 
planus is consistent with any type of lichen planus 
[2, 3]. Topical corticosteroid, low-dose oral 
corticosteroid, or phototherapy are the 
recommended therapeutic options [2, 3]. 
 
Conclusion 
Although lichen planus following radiation 
therapy is rare, it is important for clinicians to 
recognize a recent history of radiation therapy as 
a risk factor for developing lichen planus. 
Correlating the sites of radiation with the 
distribution of skin lesions may help in diagnosing 
this uncommon entity. 
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Table 1. Previously reported cases of lichen planus subsequent to oncological radiation therapy. 
 
Age/
Sex Malignancy 
RT Dose 
(Gy) 
Post-RT 
LP Onset LP Site Treatment Hep C Ref 
66/F Lung carcinoma 30 1-2 weeks 
Upper left back, 
bilateral lower 
limbs, hands, 
oral cavity 
Betamethasone valerate 
ointment; 0.1%×6 weeks-3 
months; triamcinolone 
acetonide mouthwash×3 
months** 
NS [3] 
64/F 
Breast carcinoma, 
right breast 
61 
3 months; 
13 months 
for right 
shoulder 
Right axilla, 
lateral breast, IM 
fold, right 
shoulder 
0.1% triamcinolone ointment 
1-2x daily, 3x/week  
NS [4] 
56/F 
Breast carcinoma, 
right breast 
50.4 Concurrent 
Right breast, 
trunk, bilateral 
forearms, oral 
cavity 
Initially topical ichthyol, 
followed by betamethasone 
propionate; topical tretinoin 
for oral lesions 
Neg [5] 
44/F 
Breast carcinoma, 
left breast 
60 1 month Left IM fold 
0.05% clobetasol 
propionate×1 month 
NS [6] 
59/F 
Breast carcinoma, 
left breast 
NS NS 
Left breast, arm, 
and thigh 
0.1% triamcinolone acetonide 
ointment 
Neg [7] 
67/F 
Breast carcinoma 
metastasized to 
hepatic lymph 
node and cervical 
vertebrae 
(hepatic lymph 
node & cervical 
irradiated) 
30 to 
hepatic; 
30 to 
cervical 
vertebrae 
5 weeks 
for mid-
back; 4 
weeks for 
extremities 
Mid-back, lower 
extremities, 
hands 
0.05% difluprednate 
ointment×8 weeks to mid-
back; 0.05% clobetasol 
ointment to extremities → 
unresponsive → systemic 
corticosteroid; cessation of 
nivolumab 
NS 
[8, 
9] 
58/M 
Thyroid 
carcinoma 
involving superior 
mediastinum 
59.4 1 month 
Neck, anterior 
chest 
0.05% fluocinonide, 0.05% 
clobetasol propionate at 
unspecified times over 5 
months 
Neg [10] 
46/M 
Nasopharyngeal 
carcinoma 
66.8 2 months 
Upper and lower 
lip, esophagus 
Topical mometasone furoate; 
oral prednisone 30mg/day 
Neg [11] 
48/F 
Dermatofibrosarc
oma protuberans, 
right lower back 
50 5 months Right lower back 
0.05% clobetasol propionate 
ointment×8 weeks 
NS [12] 
40/M 
Diffuse large B-
cell lymphoma of 
right knee 
45 NS 
Right knee, left 
foot 
NS NS [13] 
67/M 
Extramedullary 
plasmacytoma 
(cranial vault 
irradiated) 
45 3 months 
Scalp, lip, trunk, 
glans penis 
0.05% clobetasol propionate 
ointment, oral prednisolone 
30 mg tapered×6 weeks 
NS [14] 
68/M Penile carcinoma NS 2 months 
Pubic and 
suprapubic 
regions, bilateral 
inguinal, right 
anteromedial 
thigh 
Topical steroids Neg [15] 
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66/M 
Prostate 
carcinoma 
78 2 months 
Bilateral gluteal, 
lumbosacral, 
pelvic regions 
0.05% halobetasol ointment 
daily 
Pos 
antibody; 
Neg 
RNA 
Present 
case 
RT, radiotherapy; Gy, Gray; LP, lichen planus; Hep, hepatitis; Ref, reference; M, male; F, female; NS, not specified; IM, inframammary; Pos, 
positive; Neg, negative. 
**Patient had also received oral prednisolone followed by dexamethasone for unspecified duration to treat radiation pneumonitis and brain 
metastasis. 
 
